Intel, Optum, Relyens and Rezayat Group all invested in the surgery software provider, which is also backed by Mitsubishi, Barco Healthcare, Norgine and Takeda.

US-based surgical software and automation technology provider Caresyntax completed a $100m series C round yesterday featuring semiconductor technology producer Intel, healthcare services provider Optum, insurer Relyens and conglomerate Rezayat Group. The round was led by investment manager PFM Health Sciences and included asset manager Lauxera Capital Partners, life science-focused fund Vesalius Biocapital III, credit fund…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.